Catalent Pharma Solutions has entered into a joint marketing and collaboration agreement with One World Design and Manufacturing Group. Under the terms of the agreement, both companies will market One World's NextBottleT unit-dose compliance bottle to pharmaceutical manufacturers. One World will produce the injection-molded device and Catalent will provide filling [...]

The problem with the European pharmaceuticals industry--at least in part--is biotechnology. Or that's what the European Federation of Pharmaceutical Industries and Associations believes. The big trade association says that the slowdown in new drug approvals seen around the world can be directly linked to the biotech revolution, which has revealed a host [...]

Cubist Pharmaceuticals Inc. has signed an exclusive agreement to promote AstraZeneca Plc.’s antibiotic MERREM, Cubist said Wednesday. (AZN)[...]

Maxygen has inked a deal to sell its hemophilia drug development program to Bayer for $90 million upfront and up to $30 million in milestone payments. The program is still in the preclinical stage, with the blood clotting protein MAXY-VII scheduled for Phase I human trials in a matter of [...]

Drug addicts talk about having to "hit bottom" before they finally realize they have to do something about their problem. Are we about to see the U.S. healthcare system hit bottom? Today, UnitedHealth Group, the nation's largest health insurer, cut its earnings forecast and said it would slash 4,000 jobs. [...]

Drug maker MiddleBrook Pharmaceuticals Inc. said President and Chief Executive Edward M. Rudnic will step down under terms of Equity Group Investments LLC's $100 million investment in the company. Read More Permalink[...]